Found: 5
Select item for more details and to access through your institution.
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia.
- Published in:
- Biology Direct, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13062-024-00504-y
- By:
- Publication type:
- Article
KLF4 loss in hepatocellular carcinoma: Improving prognostic prediction and correlating immune infiltrates.
- Published in:
- Frontiers in Genetics, 2023, v. 14, p. 1, doi. 10.3389/fgene.2023.1106952
- By:
- Publication type:
- Article
Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-023-04807-y
- By:
- Publication type:
- Article
Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 11379, doi. 10.1007/s00432-023-05011-7
- By:
- Publication type:
- Article
Multiparametric MRI and Machine Learning Based Radiomic Models for Preoperative Prediction of Multiple Biological Characteristics in Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.839621
- By:
- Publication type:
- Article